Literature DB >> 2499630

Localization of an immune functional site on staphylococcal enterotoxin A using the synthetic peptide approach.

C H Pontzer1, J K Russell, H M Johnson.   

Abstract

Using the synthetic peptide approach, we have identified a part of the staphylococcal enterotoxin A (SEA) molecule that is responsible for stimulation of T cell proliferation and induction of the lymphokine IFN-gamma. Peptides were synthesized corresponding to amino acids 1 to 27, SEA(1-27), and 28 to 45, SEA(28-45). Both peptides were tested for direct competition with SEA for blockage of SEA induced proliferation and production of IFN-gamma by T cells. Further, antibodies were produced to the peptides and tested for their ability to bind to SEA and block SEA function. SEA (1-27), but not SEA (28-45), blocked proliferation of human peripheral T cells and induction of IFN-gamma by the T cell line, L12-R4. The inhibitory effects were specific, because SEA (1-27) did not inhibit the induction of T cell proliferation by the mitogen PHA. Consistent with the direct inhibition of function, antibodies to SEA (1-27), but not SEA (28-45), neutralized the mitogenic activity of SEA on human PBL. The data suggest that a functional site on SEA that is responsible for its modulation of T cell function involves the N-terminal 27 amino acids. Residues 1 to 27 of SEA could potentially interact at either the level of the TCR or may block the proposed binding of SEA to class II MHC Ag, based on recent data showing that these molecules are involved in SEA-induced proliferation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2499630

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

1.  Mapping of staphylococcal enterotoxin A functional binding sites and presentation by monoclonal antibodies and fusion proteins.

Authors:  W Mahana
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

2.  T-cell antigen receptor binding sites for the microbial superantigen staphylococcal enterotoxin A.

Authors:  C H Pontzer; M J Irwin; N R Gascoigne; H M Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

3.  Structural basis for differential binding of staphylococcal enterotoxin A and toxic shock syndrome toxin 1 to class II major histocompatibility molecules.

Authors:  C H Pontzer; J K Russell; H M Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

4.  Mutational analysis of superantigen activity responsible for the induction of skin erythema by streptococcal pyrogenic exotoxin C.

Authors:  J Yamaoka; E Nakamura; Y Takeda; S Imamura; N Minato
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

Review 5.  Bacterial pyrogenic exotoxins as superantigens.

Authors:  M Kotb
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

6.  Identification of staphylococcal enterotoxin B sequences important for induction of lymphocyte proliferation by using synthetic peptide fragments of the toxin.

Authors:  M Jett; R Neill; C Welch; T Boyle; E Bernton; D Hoover; G Lowell; R E Hunt; S Chatterjee; P Gemski
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

Review 7.  Benchmarking B-cell epitope prediction for the design of peptide-based vaccines: problems and prospects.

Authors:  Salvador Eugenio C Caoili
Journal:  J Biomed Biotechnol       Date:  2010-03-30

8.  Murine macrophage activation by staphylococcal exotoxins.

Authors:  S D Fleming; J J Iandolo; S K Chapes
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

9.  Lack of complete correlation between emetic and T-cell-stimulatory activities of staphylococcal enterotoxins.

Authors:  T O Harris; D Grossman; J W Kappler; P Marrack; R R Rich; M J Betley
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

10.  The carboxyl-terminal region of staphylococcal enterotoxin type A is required for a fully active molecule.

Authors:  W O Hufnagle; M T Tremaine; M J Betley
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.